These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6156212)

  • 21. Further characterization of immunological unresponsiveness induced in mice by ultraviolet radiation. Growth and induction of nonultraviolet-induced tumors in ultraviolet-irradiated mice.
    Kripke ML; Thorn RM; Lill PH; Civin CI; Pazmiño NH; Fisher MS
    Transplantation; 1979 Sep; 28(3):212-7. PubMed ID: 91250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Current and prospective problems in tumor immunology].
    Pitzurra M
    Boll Ist Sieroter Milan; 1971; 50(3):209-20. PubMed ID: 4947785
    [No Abstract]   [Full Text] [Related]  

  • 23. Clonal analysis of B and T cell responses to Ia antigens. IV. Proliferative T cell clones recognizing E beta and/or E alpha allodeterminants.
    Pierres A; Pierres M
    J Immunol; 1983 Mar; 130(3):1262-7. PubMed ID: 6185575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishment of a tumor-specific immunotherapy model utilizing TNP-reactive helper T cell activity and its application to the autochthonous tumor system.
    Fujiwara H; Aoki H; Yoshioka T; Tomita S; Ikegami R; Hamaoka T
    J Immunol; 1984 Jul; 133(1):509-14. PubMed ID: 6233375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Independent immunodominant and immunorecessive tumor-specific antigens on a malignant tumor: antigenic dissection with cytolytic T cell clones.
    Wortzel RD; Urban JL; Philipps C; Fitch FW; Schreiber H
    J Immunol; 1983 May; 130(5):2461-6. PubMed ID: 6187859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antigenic cancer cells that escape immune destruction are stimulated by host cells.
    Seung LP; Seung SK; Schreiber H
    Cancer Res; 1995 Nov; 55(21):5094-100. PubMed ID: 7585557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Virus specific antigens in BK virus-transformed cells detected by cell-mediated immune reactions.
    Karjalainen HE; Laaksonen AM; Mäntyjärvi RA
    Med Biol; 1983 Feb; 61(1):73-8. PubMed ID: 6302408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific antigens on methylcholanthrene-induced tumors of mice.
    Lennox ES; Lowe AD; Cohn J; Evan G
    Transplant Proc; 1981 Dec; 13(4):1759-61. PubMed ID: 6173943
    [No Abstract]   [Full Text] [Related]  

  • 29. Occurrence of shared nonviral tumor-associated transplantation-type antigens among C3H/He mammary carcinomas.
    Vaage J
    Cancer Res; 1984 May; 44(5):1876-9. PubMed ID: 6201265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenotypic and physical characteristics of the lymphoid cells involved in the immunity to syngeneic UV-induced tumors.
    Daynes RA; Schmitt MK; Roberts LK; Spellman CW
    J Immunol; 1979 Jun; 122(6):2458-64. PubMed ID: 312869
    [No Abstract]   [Full Text] [Related]  

  • 31. H-2 restriction of the T cell response to chemically induced tumors: evidence from F1 replaced by parent chimeras.
    Lannin DR; Yu S; McKhann CF
    J Immunol; 1982 Jan; 128(1):263-8. PubMed ID: 6459368
    [No Abstract]   [Full Text] [Related]  

  • 32. [Tumor-specific immunotherapy: active immunotherapy by augmenting the induction of tumor-specific effector T cells through a T-T cell interaction mechanism].
    Kosugi A; Fujiwara H; Hamaoka T
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1527-35. PubMed ID: 6236750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-reactive transplantation antigens between UV-irradiated skin and UV-induced tumors.
    Spellman CW; Daynes RA
    Photodermatol; 1984 Aug; 1(4):164-9. PubMed ID: 6397735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylcholanthrene-induced mouse sarcomas express individually distinct major histocompatibility complex class I-associated peptides recognized by specific CD8+ T-cell lines.
    Kono K; Petersson M; Ciupitu AM; Wen T; Klein G; Kiessling R
    Cancer Res; 1995 Dec; 55(23):5648-55. PubMed ID: 7585649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adoption of tumor immunity: role of the major histocompatibility complex.
    Poupon MF; Payelle B; Lespinats G
    J Immunol; 1981 Jun; 126(6):2342-6. PubMed ID: 6971896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Augmentation of syngeneic tumor-specific immunity by semiallogeneic cell hybrids.
    Toffaletti DL; Darrow TL; Scott DW
    J Immunol; 1983 Jun; 130(6):2982-6. PubMed ID: 6189910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of major histocompatibility complex in genetic regulation of immunologic responsiveness.
    Benacerraf B
    Transplant Proc; 1977 Mar; 9(1):825-31. PubMed ID: 325816
    [No Abstract]   [Full Text] [Related]  

  • 38. Antigen presentation by murine epidermal langerhans cells and its alteration by ultraviolet B light.
    Stingl G; Gazze-Stingl LA; Aberer W; Wolff K
    J Immunol; 1981 Oct; 127(4):1707-13. PubMed ID: 6168700
    [No Abstract]   [Full Text] [Related]  

  • 39. Tumour rejection antigens associated with carcinogen-induced tumours.
    Baldwin RW; Price MR
    Ric Clin Lab; 1977; 7(2):102-11. PubMed ID: 72398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.